NDAINJECTIONINJECTABLEPriority Review
Approved
Mar 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CLAFORAN (cefotaxime sodium) is a third-generation cephalosporin antibiotic administered via injection for treatment of bacterial infections including meningitis, septicemia, and other serious infections. It works by inhibiting bacterial cell wall synthesis, making it bactericidal against a broad spectrum of gram-positive and gram-negative organisms.
LOE Approaching
LOE-approaching lifecycle with moderate competitive pressure (30) suggests team focus is on margin management and channel optimization rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CLAFORAN offers career opportunities in mature-market management, hospital channel strategy, and price/reimbursement defense—skills highly transferable to other LOE-stage products. This role emphasizes operational excellence and stakeholder management rather than launch-phase excitement or clinical innovation.
Hospital Account ManagerManaged Care Director
Worked on CLAFORAN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.